KRYS
Krystal Biotech, Inc.
Krystal Biotech, Inc. (KRYS) has 11 SEC Form 4 filings (112 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jun 26, 2026.
The most active filer is President and CEO Krishnan Krish S with 3 filings. Insiders have net sold $48.7M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Krish S. Krishnan
- Employees:275
- HQ:Pittsburgh, PA, US
- IPO:2017-09-20
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$59.7M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$10.1B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| EVP, General Counsel | Sale | 1,000 | $347K | Jun 26 | SEC ↗ | |
Krishnan SumaFirst in 3 months | President, R&D | Sale | 25,000 | $7.7M | Jun 5 | SEC ↗ |
Krishnan Krish SFirst in 3 months | President and CEO | Sale | 25,000 | $7.7M | Jun 5 | SEC ↗ |
Thomas John CharlesFirst filing | EVP, General Counsel | Sale | 642 | $194K | May 27 | SEC ↗ |
Krishnan Krish SFirst in 3 months | President and CEO | Sale | 25,000 | $6.6M | Mar 6 | SEC ↗ |
Krishnan SumaFirst filing | President, R&D | Sale | 25,000 | $6.6M | Mar 6 | SEC ↗ |
JANNEY DANIELFirst filing | Director | Sale | 51,720 | $13.8M | Feb 26 | SEC ↗ |
JANNEY DANIELFirst filing | Director | Sale | 700 | $193K | Feb 26 | SEC ↗ |
JANNEY DANIELFirst filing | Director | Sale | 7,741 | $2.1M | Feb 26 | SEC ↗ |
ROMANO KATHRYNFirst filing | Chief Accounting Officer | Sale | 12,500 | $3.4M | Feb 11 | SEC ↗ |
Krishnan Krish SFirst filing | President and CEO | Sale | 50,000 | $11.0M | Dec 5 | SEC ↗ |
Related companies
Krystal Biotech, Inc. is in the Healthcare sector.